This leads to relatively smooth (though not flawless) northbound trajectories and strong returns for most stocks over a ...

Olin shows strong cash flow potential, smart capital allocation, and undervaluation based on DCF analysis despite some risks.

Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

France is facing critical shortages of a number of drugs, and one need look no further for a cause than a price control ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar ...

Six so-called patient advocacy groups are working to advance corporate profits in the pharmaceutical industry by routinely ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

2 M&A plays a key role in bringing highly lucrative medications to market, as large pharmaceutical companies often look to invest in young biotechnology companies for their innovative products.

The White House requested the original assessment in February as it was preparing Mr. Trump’s Alien Enemies Act proclamation.

When multibillion-pound global corporations invest huge sums in medical companies to develop new treatments for serious ...